We are live on ! Find out more
GIP

Granite Investment Partners Portfolio holdings

AUM $1.95B
1-Year Est. Return 49.89%
This Fund
S&P 500
This Quarter Est. Return
+5.89%
1 Year Est. Return
+49.89%
3 Year Est. Return
+130.82%
5 Year Est. Return
+170.12%
10 Year Est. Return
+1,227.59%
AUM
$1.69B
AUM Growth
-$74M
Cap. Flow
-$133M
Cap. Flow %
-7.86%
Top 10 Hldgs %
25.07%
Holding
271
New
22
Increased
48
Reduced
135
Closed
27

Top Buys

Rank Stock Value
1
PSN icon
Parsons
PSN
+$13.1M
2
NOVT icon
Novanta
NOVT
+$12.9M
3
DOCN icon
DigitalOcean
DOCN
+$9.07M
4
EXPO icon
Exponent
EXPO
+$8.91M
5
APLS
Apellis Pharmaceuticals
APLS
+$7.67M

Sector Composition

Rank Sector Weight
1 Industrials 26.17%
2 Technology 25.19%
3 Healthcare 15.22%
4 Financials 10.42%
5 Consumer Discretionary 6.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMTM
201
Amentum Holdings
AMTM
$6.05B
$384K 0.02%
13,248
-1,510
-10% -$38.6K
IONS icon
202
Ionis Pharmaceuticals
IONS
$9.4B
$380K 0.02%
4,806
-23,227
-83% -$1.75M
ISRG icon
203
Intuitive Surgical
ISRG
$134B
$378K 0.02%
668
-128
-16% -$68.1K
TSLA icon
204
Tesla
TSLA
$1.3T
$371K 0.02%
824
FCX icon
205
Freeport-McMoran
FCX
$97.5B
$357K 0.02%
7,032
-1,810
-20% -$78.4K
SCHA icon
206
Schwab U.S Small- Cap ETF
SCHA
$23.1B
$347K 0.02%
12,169
+1
+0% +$28
RAL
207
Ralliant Corp
RAL
$7.46B
$345K 0.02%
6,782
-2,755
-29% -$129K
SRCE icon
208
1st Source
SRCE
$2.12B
$337K 0.02%
5,392
-26,257
-83% -$1.62M
BAC icon
209
Bank of America
BAC
$442B
$337K 0.02%
6,125
CFR icon
210
Cullen/Frost Bankers
CFR
$10.2B
$327K 0.02%
2,579
-13,020
-83% -$1.63M
SHEL icon
211
Shell
SHEL
$245B
$320K 0.02%
4,358
NUE icon
212
Nucor
NUE
$62.1B
$312K 0.02%
1,911
-1,058
-36% -$159K
IJH icon
213
iShares Core S&P Mid-Cap ETF
IJH
$127B
$301K 0.02%
4,555
PCOR icon
214
Procore
PCOR
$8.67B
$299K 0.02%
4,110
-19,873
-83% -$1.47M
AVAV icon
215
AeroVironment
AVAV
$9.45B
$288K 0.02%
1,191
-4,078
-77% -$1.28M
SPXC icon
216
SPX Corp
SPXC
$10.8B
$265K 0.02%
1,327
-8,587
-87% -$1.75M
CNM icon
217
Core & Main
CNM
$8.71B
$265K 0.02%
5,103
-25,832
-84% -$1.32M
JAZZ icon
218
Jazz Pharmaceuticals
JAZZ
$16.7B
$263K 0.02%
1,545
-7,630
-83% -$1.17M
SARO
219
StandardAero Inc
SARO
$9.7B
$260K 0.02%
+9,058
New +$247K
WING icon
220
Wingstop
WING
$3.18B
$259K 0.02%
1,085
-3,661
-77% -$907K
NEE icon
221
NextEra Energy
NEE
$177B
$257K 0.02%
3,200
VBK icon
222
Vanguard Morningstar Small-Cap Growth ETF
VBK
$24.6B
$249K 0.01%
+823
New +$248K
ANET icon
223
Arista Networks
ANET
$238B
$238K 0.01%
1,818
+340
+23% +$46.8K
BIRK icon
224
Birkenstock
BIRK
$7.07B
$235K 0.01%
+5,740
New +$243K
INTC icon
225
Intel
INTC
$513B
$213K 0.01%
+5,764
New +$218K

Similar funds

Granite Investment Partners's Q4 2025 Portfolio in Review

As of Q4 2025, Granite Investment Partners held 271 positions worth $1.69B, down 4.2% from $1.76B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Granite Investment Partners withdrew a net $133M in Q4 2025, closing 27 positions and reducing 135 holdings. Its most notable exit was Amicus Therapeutics, an estimated $16.7M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 26% of assets, down from 27% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Granite Investment Partners opened a new position in Novanta worth $13.5M.

  • Granite Investment Partners's largest Q4 2025 buy was Novanta: 113,400 shares worth $13.5M.
  • Granite Investment Partners added most to Parsons in Q4 2025, an estimated $13.1M increase.
  • Granite Investment Partners's biggest Q4 2025 reduction was Tower Semiconductor, cutting an estimated $20.1M.
  • Granite Investment Partners fully exited Amicus Therapeutics in Q4 2025, selling an estimated $16.7M.
  • Granite Investment Partners's ten largest holdings make up 25% of its $1.69B portfolio in Q4 2025.
  • Granite Investment Partners opened 22 new positions and closed 27 in Q4 2025.
  • Granite Investment Partners's portfolio value fell 4.2% quarter-over-quarter to $1.69B.

Based on Granite Investment Partners's 13F filing for Q4 2025, filed 12 Feb 2026.